Search
Search Results
Found 11 items.
-
Factor XI inhibitors: a new option for the prevention and treatment of cancer-associated thrombosis
Published: 16 May 2024325PDF: 137 -
Pleiotropic effects of anti-thrombotic therapies: have direct oral anticoagulants any anti-inflammatory effect?
Published: 14 December 2022592PDF: 258 -
-
Personalized bleeding risk assessment for atrial fibrillation patients on direct oral anticoagulants: the DOAC score
Published: 11 October 20231326PDF: 171 -
New perspectives for prevention of the post-thrombotic syndrome
Published: 22 March 20221208PDF: 394 -
Safety and efficacy of treatment with vitamin K antagonists in patients managed in a network of anticoagulation services or as routine general care
Published: 15 April 2022483PDF: 180Supplementary Files: 52 -
Evaluation of Coaguchek®Pro II coagulation testing device performance to assess direct oral anticoagulant action. The DOAC-CHECK study
Published: 1 December 20221160PDF: 229 -
Location of metastasis and complications in patients with venous thromboembolism and cancer: systematic review
Published: 16 May 2024232PDF: 79 -
Venous thromboembolism treatment in patients with cancer: reflections on an evolving landscape
Published: 29 February 20241190PDF: 180 -
Factor XI inhibitors in adjunct to antiplatelet therapy: the ultimate dual-pathway inhibition?
Published: 3 August 20231098PDF: 386 -
Management of anticoagulation in atrial fibrillation patients in Italy: insight from the Atrial Fibrillation-Survey on Anticoagulated Patients Register (AF-START)
Published: 27 June 2023939PDF: 210Supplementary File: 95
1 - 11 of 11 items